S. Watahiki

发表

Selection of a virus strain resistant to entecavir in a nucleoside-naive patient with hepatitis B of genotype H.

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Prolonged hepatitis after acute infection with genotype H hepatitis B virus.

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2007, Internal medicine.

Response to long‐term lamivudine treatment in patients infected with hepatitis B virus genotypes A, B, and C

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2006, Journal of medical virology.

Exploratory study on telaprevir given every 8 h at 500 mg or 750 mg with peginterferon‐alpha‐2b and ribavirin in hepatitis C patients

Yoshiyuki Suzuki, H. Tsuda, M. Kobayashi, 2013, Hepatology research : the official journal of the Japan Society of Hepatology.

Rapid loss of hepatitis C virus genotype 1b from serum in patients receiving a triple treatment with telaprevir (MP‐424), pegylated interferon and ribavirin for 12 weeks

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2009, Hepatology research : the official journal of the Japan Society of Hepatology.

Predictive factors of virological non‐response to interferon–ribavirin combination therapy for patients infected with hepatitis C virus of genotype1b and high viral load

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2006, Journal of medical virology.

Association of Amino Acid Substitution Pattern in Core Protein of Hepatitis C Virus Genotype 1b High Viral Load and Non-Virological Response to Interferon-Ribavirin Combination Therapy

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2005, Intervirology.

Development of hepatocellular carcinoma in elderly patients with chronic hepatitis C with or without elevated aspartate and alanine aminotransferase levels

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2009, Scandinavian journal of gastroenterology.

Low risk of adefovir resistance in lamivudine-resistant chronic hepatitis B patients treated with adefovir plus lamivudine combination therapy: two-year follow-up.

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2008, Journal of hepatology.

Sustained virological response in a patient with chronic hepatitis C treated by monotherapy with the NS3-4A protease inhibitor telaprevir.

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2010, Journal of Clinical Virology.

Long-term continuous entecavir therapy in nucleos(t)ide-naïve chronic hepatitis B patients.

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2012, Journal of hepatology.

Virologic breakthrough in a patient with chronic hepatitis B by combination treatment with tenofovir disoproxil fumarate and entecavir

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2014, Drug design, development and therapy.

Long-term efficacy and emergence of multidrug resistance in patients with lamivudine-refractory chronic hepatitis B treated by combination therapy with adefovir plus lamivudine

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2014, Journal of Gastroenterology.

Loss of hepatitis B surface antigen from the serum of patients with chronic hepatitis treated with lamivudine

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2007, Journal of medical virology.

Correlation of YMDD mutation and breakthrough hepatitis with hepatitis B virus DNA and serum ALT during lamivudine treatment

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2010, Hepatology research : the official journal of the Japan Society of Hepatology.

Clinical and virological features of non‐breakthrough and severe exacerbation due to lamivudine‐resistant hepatitis B virus mutants

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2006, Journal of medical virology.

Changes in viral loads of lamivudine‐resistant mutants during entecavir therapy

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

Efficacy of switching to entecavir monotherapy in Japanese lamivudine‐pretreated patients

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2010, Journal of gastroenterology and hepatology.

Increase of rtA181T mutant strains during entecavir therapy for a patient with chronic hepatitis B virus infection

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2010 .

Long‐term entecavir therapy results in falls in serum hepatitis B surface antigen levels and seroclearance in nucleos(t)ide‐naïve chronic hepatitis B patients

Y. Suzuki, M. Kobayashi, K. Ikeda, 2014, Journal of viral hepatitis.

Change of hepatitis B virus genotypes in acute and chronic infections in Japan

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2008, Journal of medical virology.

Influence of amino‐acid polymorphism in the core protein on progression of liver disease in patients infected with hepatitis C virus genotype 1b

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2010, Journal of medical virology.

Prevalence of hepatitis C virus variants resistant to NS3 protease inhibitors or the NS5A inhibitor (BMS-790052) in hepatitis patients with genotype 1b.

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

A novel entecavir-resistant virus with patient of lamivudine-resistant hepatitis B virus mutant

Yoshiyuki Suzuki, K. Ikeda, H. Kumada, 2005 .

Rapid loss of hepatitis C virus genotype 1b from serum in patients receiving a triple treatment with telaprevir (MP‐424), pegylated interferon and ribavirin for 12 weeks

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2009, Hepatology research : the official journal of the Japan Society of Hepatology.

Low risk of adefovir resistance in lamivudine-resistant chronic hepatitis B patients treated with adefovir plus lamivudine combination therapy: two-year follow-up.

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2008, Journal of hepatology.